04/28/2024
11:15 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form EFFECT | |
04/24/2024
3:40 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form POS AM | |
04/10/2024
11:15 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form EFFECT | |
04/10/2024
3:40 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 424B3 | |
04/10/2024
8:58 AM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form CERT | |
04/10/2024
6:00 AM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-A12B | |
04/04/2024
4:32 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form S-1/A | |
|
03/27/2024
4:27 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/21/2024
7:41 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/15/2024
3:15 PM | 5AM CO-INVESTORS II LP (Reporting)
5AM Partners II, LLC (Reporting)
5AM Partners VII, LLC (Reporting)
5AM Ventures II LP (Reporting)
5AM Ventures VII, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
PARMAR KUSH (Reporting)
ROCKLAGE SCOTT M (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
6:28 PM | 5AM Partners VII, LLC (Filed by)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form SC 13D/A | |
03/13/2024
3:13 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
6:53 PM | Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:23 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
3:18 PM | Jenkins Annalisa (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/04/2024
5:13 AM | DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4/A | |
03/04/2024
5:15 AM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4/A | |
03/04/2024
5:17 AM | Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/04/2024
5:19 AM | Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:20 AM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
TYLE PRAVEEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:23 AM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Ward Keith Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:24 AM | DALESANDRO MARGARET (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:24 PM | DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:42 PM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
11:08 AM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/08/2024
8:51 AM | Skye Bioscience (Subject)
Skye Bioscience (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G | |
02/02/2024
3:32 PM | 5AM CO-INVESTORS II LP (Reporting)
5AM CO-INVESTORS II LP (Reporting)
5AM Partners II, LLC (Reporting)
5AM Partners II, LLC (Reporting)
5AM Partners VII, LLC (Reporting)
5AM Ventures II LP (Reporting)
5AM Ventures VII, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
DIEKMAN JOHN D (Reporting)
PARMAR KUSH (Reporting)
PARMAR KUSH (Reporting)
ROCKLAGE SCOTT M (Reporting)
ROCKLAGE SCOTT M (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:35 PM | Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
7:02 AM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
4:04 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
7:21 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
7:29 PM | Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
7:29 PM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
TYLE PRAVEEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
7:29 PM | Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
7:29 PM | DALESANDRO MARGARET (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
7:29 PM | DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
7:29 PM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
7:30 PM | Charych Deborah H. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
7:32 PM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Ward Keith Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
5:16 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form DEF 14C | |
10/03/2023
3:34 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
My system predicted the BA collapse – now it’s issuing an AI warning (Ad) Even after several plane crashes and equipment malfunctions... a congressional hearing... and the worst PR firestorm in recent memory...
The FTC's commission chair Lina Khan still deems Boeing (BA), "too big to fail"  Click to see why a similar situation is currently brewing in the AI market... |
10/03/2023
3:12 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form PRE 14C | |
09/07/2023
12:15 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2023
8:36 PM | Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
6:25 PM | Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
5:53 PM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
5:39 PM | DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
5:17 PM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Ward Keith Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
5:21 PM | DALESANDRO MARGARET (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
5:22 PM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
TYLE PRAVEEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
5:02 PM | Charych Deborah H. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2023
3:17 PM | Skye Bioscience (Subject)
Skye Bioscience (Subject)
Versant Venture Capital III, L.P. (Filed by)
| Form SC 13G | |
08/28/2023
3:18 PM | 5AM CO-INVESTORS II LP (Reporting)
5AM Partners II, LLC (Reporting)
5AM Partners VII, LLC (Reporting)
5AM Ventures II LP (Reporting)
5AM Ventures VII, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
PARMAR KUSH (Reporting)
ROCKLAGE SCOTT M (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/22/2023
4:19 PM | Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/22/2023
4:19 PM | Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/22/2023
4:21 PM | Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
7:36 AM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
